JULIUS EDWARD CANTUBA: Open Payments
NPI 1740052539 · PLYMOUTH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $548 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $334 |
| Otsuka America Pharmaceutical, Inc. | 3 | $273 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| ABBVIE INC. | 5 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: REXULTI, LYBALVI, COBENFY, VRAYLAR, CAPLYTA, ARISTADA, TRINTELLIX, SPRAVATO.
Industry payments across MI — which companies pay providers there.
